Neha Gupta
Tue, November 18, 2025 astatine 3:45 AM CST 2 min read
According to the analyst, Twist’s innovation spurred beardown gross maturation – 22.7% implicit the past twelvemonth and a five-year CAGR of 42%. Etoch noted further that portion the cistron editing scenery is competitive, Twist’s outgo enactment and investments are helping it summation marketplace share. The expert expects the institution to scope adjusted EBITDA break-even by the extremity of fiscal twelvemonth 2026.
Etoch identified NGS arsenic a large maturation opportunity, peculiarly arsenic its adoption expands successful areas specified arsenic liquid biopsy and minimal residual illness (MRD) monitoring. He besides cited enlargement into adjacent markets arsenic a mode that Twist is strengthening its lawsuit relationships.
Twist Bioscience Corporation (NASDAQ:TWST) is simply a synthetic biology company. It manufactures DNA astatine standard utilizing a proprietary silicon-based platform. This enables accelerated cistron synthesis for applications successful cause discovery, diagnostics, and precision medicine. Its main products are customized DNA sequences and cistron libraries.
While we admit the imaginable of TWST arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 10 Best European Bank Stocks to Buy Now and 11 Best Solar Energy Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

3 days ago
5






English (CA) ·
English (US) ·
Spanish (MX) ·